The aim was to disrupt the diagnostics market with a lancing system that would significantly improve the patient’s experience. Our development and regulatory teams helped our client launch the first FDA & CE approved device for fully automated, virtually pain-free lancing.
Unilever identified an opportunity to trial a new business model and an innovative food service dispensing system for their leading ice cream brand. We provided end-to-end support to design, develop, and build 50 connected devices which were scaled up and pilot launched in outlets across Europe.
We were asked to resolve the difficult engineering and manufacturing issues that were jeopardising this novel inhaler’s launch. Our team identified and resolved the problems, validated the design and production tooling so Voke could gain CE approval and enter volume manufacture.
CDP’s partner QuantuMDx has now embarked on £11 million scale-up to mass manufacture of their Q-POC™ device.
Mike Cane reveals the strategies that delivered continued growth this year, ensuring that innovation never stops.
Jez shares some of the approaches we use at CDP to make sure our teams can work effectively in virtual meetings.
Mark discusses how the interplay between choice of materials and product design provides unique opportunities for innovation.
Crossing the chasm from design to manufacture can create an acute case of innovation vertigo. Carl Pullen, senior consultant mechanical engineer and Wade Tipton, partner responsible for quality and manufacturing at Cambridge Design Partnership discuss the benefits of using short-run manufacturing to solve the challenges of design transfer in medical…
The challenges of bridging the ‘design transfer chasm’ are well known in the medical device industry. If your approach to design and innovation has not fully anticipated the intricacies of volume production in a regulated environment, then difficulties will arise when it is sent to your manufacturing partner to be…
We are all manufacturers. Without appreciating it we manufacture products ourselves every day. Think back to breakfast this morning – did you make toast? Most mornings my son has toast for breakfast. The process of making his toast mimics the work I do every day at CDP in the development…
This month’s Manufacturing Medicines Industry Partnership (MMIP) conference – Propelling growth: taking the next step in innovative medicines manufacturing – took place at an exciting time for the pharma industry. Advanced therapies (ATs) – such as cell therapies in which patients are treated with living cells – have been under development for…
When pharmaceutical companies launch a new product, often it is a combination of a new drug in an existing, proven delivery device. Because all new pharma products have full regulatory scrutiny, it is important to make sure the medical device design history file (DHF) is up to date and meets…